Siren »

Achilles Therapeutics shares owned by Siren

Quarter-by-quarter ownership of Achilles Therapeutics (ACHL) shares owned by Siren from 13F filings

Historical chart of Siren investment in Achilles Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Achilles Therapeutics held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Achilles Therapeutics by Siren

Quarter filed Position value Share count Share price at filing
2024-12-31 $861k 755k 1.14
2024-09-30 $771k 755k 1.02

More positions owned by Siren

Scholar Rock Hldg Corp (SRRK)
Kymera Therapeutics (KYMR)
BeOne Medicines Sponsored Ads (ONC)
Arrowhead Pharmaceuticals (ARWR)
Bicara Therapeutics (BCAX)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Crinetics Pharmaceuticals In (CRNX)
Edgewise Therapeutics (EWTX)
Disc Medicine (IRON)
Dyne Therapeutics (DYN)
Apellis Pharmaceuticals (APLS)
Avidity Biosciences Ord (RNA)
Stoke Therapeutics (STOK)
Lexicon Pharmaceuticals Com New (LXRX)
Rhythm Pharmaceuticals (RYTM)

View all positions for Siren

Top funds holding Achilles Therapeutics

Rhumbline Advisers
GAMMA Investing

View all funds holding Achilles Therapeutics